JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gao, E.
Right arrow Articles by Horwitz, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gao, E.
Right arrow Articles by Horwitz, J.

Vol. 285, Issue 1, 186-192, April 1998

Age-Related Decline in Beta Adrenergic and Adenosine A1 Receptor Function in the Heart Are Attenuated by Dietary Restriction1

Erhe Gao, David L. Snyder, Jay Roberts, Eitan Friedman, Guoping Cai, Amir Pelleg and Joel Horwitz

Department of Pharmacology, MCP black-diamond  Hahnemann School of Medicine, Allegheny University of the Health Sciences, Philadelphia, Pennsylvania


    Abstract
Top
Abstract
Introduction
Methods
Results
Discussion
References

Previously published reports from this laboratory have shown that the antiadrenergic effect of adenosine A1 agonists declines with age in the rat heart [Gao et al. (1997) J Mol Cell Cardiol 29:593-602] and that this decline may be caused by a decrease in coupling between adenosine A1 receptors (AdoA1R) and guanine nucleotide-binding proteins [Cai et al. (1997) Circ Res 81:1065-1071]. Dietary restriction (DR; 60% calories of ad libitum) has been shown to attenuate age-related changes in cellular signal transduction pathways. Therefore, the present study investigated whether DR altered the age-related changes in AdoA1R-mediated function in senescent rat hearts. Ventricular membranes were isolated from the hearts of ad libitum (AL) fed and DR male F344 rats that were 6, 12 and 24 months of age. In AL rats, there was an age-related decline in isoproterenol (ISO)-stimulated adenylyl cyclase when compared with the 6-month-old rats. The decline in ISO-stimulated cyclase was attenuated in DR animals. In AL rats, inhibition of ISO-stimulated adenylyl cyclase by the AdoA1R agonist, N6-p-sulfophenyladenosine (SPA) decreased with age. In DR rats, the age-related decline in inhibition was attenuated. Previous results from this laboratory indicated that in AL fed rats, there was an age-related decrease in the percentage of high-affinity binding sites for SPA, from 55% at 6 months to 23% at 24 months. Diet restriction attenuated this age-related shift in high-affinity binding sites so that the percentage of high-affinity sites at 24 months was 42%. Our results suggest that DR maintains AdoA1R function by preventing a loss of high-affinity AdoA1R sites.


    Introduction
Top
Abstract
Introduction
Methods
Results
Discussion
References

Adenosine is a byproduct of ATP degradation which is released from myocytes under ischemic and hypoxic conditions (Sparks and Bardenhauer, 1986). The antiadrenergic action of adenosine reduces oxygen demand when oxygen supply is limited (Huang and Drummond, 1976; Belardinelli and Isenberg, 1983; Achterberg et al., 1985; Romano et al., 1991). Postsynaptic inhibition of myocyte responses to beta adrenoceptor stimulation are mediated through the AdoA1R coupled to the inhibitory guanine nucleotide-binding protein Gi (Evans and Schenden 1982; Linden et al., 1985; Martens et al., 1987; Henrich et al., 1987).

Studies from our group have shown that AdoA1R-mediated antiadrenergic effects decline with age in the rat heart (Gao et al., 1997). The specific AdoA1R agonists, N6-cyclopentyladenosine (Bruns et al., 1986) and SPA (Jacobsen et al., 1992); inhibit ISO- and forskolin-stimulated adenylyl cyclase activity in cardiac membranes in 6-month-old but not in 24-month-old male F344 rats (Gao et al., 1997). We have also shown that the age-related decrease in AdoA1R function in the ventricle may be caused by a decrease in AdoA1R/G-protein coupling (Cai et al., 1997). Thus the protective actions of adenosine may be diminished in the elderly heart.

Restriction of caloric intake to 60% - 70% of ad libitum intake postpones the occurrence of pathology, extends life-span in the rat (Snyder et al., 1990; Masoro, 1993) and has been shown to attenuate the age-related changes in several physiological processes (Yu, 1994). These include age-related changes in the following parameters of signal transduction pathways: beta adrenergic receptors in the liver (Dax et al., 1989), beta adrenergic stimulation of adenylyl cyclase in the liver (Katz, 1988) and lung (Scarpace and Yu, 1987) and alpha adrenergic receptors in the aorta (Gurdal et al., 1995) and parotid gland (Chen et al., 1997). The present study further characterizes the age-related changes in beta adrenergic receptor- and AdoA1R-mediated function in senescent rat hearts by investigating these receptor systems in DR rats.

    Methods
Top
Abstract
Introduction
Methods
Results
Discussion
References

Reagents. Adenosine 5'-triphosphate, tetra (triethylammonium) salt, [alpha -32P] (32P-ATP) and 3H-DPCPX were obtained from NEN (Boston, MA). Adenosine-3'5'-cyclic phosphate [2,8-3H], ammonium salt (3H-cAMP) was obtained from American Radiolabeled Chemicals (St. Louis, MO). SPA and 8-SPT were obtained from Research Biochemical International (Natick, MA). 5'-Guanylylimidodiphosphate (Gpp(NH)p), adenosine deaminase and other chemicals as well as chromatographic alumina WN-3 were purchased from Sigma Chemical Company (St. Louis, MO). Dowex AG50 WX4 cation exchange resin (200-400 mesh) was purchased from Bio-Rad (Melville, NY).

Animals. These studies have been carried out according to the Guide for the Care and Use of Laboratory Animals as adopted by the National Institutes of Health. Male 6-, 12-, and 24-month-old Fisher 344 rats were reared and maintained at the National Center for Toxicological Research (NCTR) animal colony. These rats were fed either AL or restricted to 60% of the food intake of the ad libitum fed rats (DR) from the time of weaning. They were shipped approximately 1 month before use. In our institution, rats were housed in a barrier facility, in standard filter topped cages, one rat per cage. Room temperature was set at 21 ± 1°C; the light/dark cycle was 12 h; humidity was controlled at 40 to 65%. The animals were fed a pasteurized rodent diet and autoclaved water adjusted to pH 3.

Membrane preparation for adenylyl cyclase assay. Crude cardiac ventricular membranes were prepared from rat hearts as described previously (Gao et al., 1997). Rats were decapitated and the hearts were quickly excised and stored in ice-cold buffer containing 10% sucrose, 1 mM EGTA and 5 mM Tris-HCl at pH 7.4. Atria were detached and ventricles were minced and homogenized for 10 s with a polytron set at power 6. The suspension was centrifuged at 1,000 × g for 10 min, and the supernatant was then centrifuged at 27,000 × g for 20 min. The pellet was washed twice and resuspended in 100 mM Tris-HCl buffer (pH 7.4). Protein concentration was measured by the method of Bradford (1976). All the membrane preparations were frozen at -70°C.

Membrane preparation for adenosine A1 receptor binding assay. The cardiac membranes used for receptor binding were prepared according to the method of Lee et al. (1993) with minor modification. Hearts were washed in ice-cold calcium-free phosphate-buffered saline containing 1 mM EDTA. The ventricles were homogenized as above. The suspension was centrifuged at 1,000 × g for 10 min, and the supernatant was then centrifuged at 49,000 × g for 20 min. The pellet was washed twice and resuspended in a buffer containing 10 mM HEPES, 0.1 mM EDTA, 0.1 mM benzamidine (pH 7.4). The membrane was incubated with adenosine deaminase (2 U/ml) at 25°C for 20 min before being stored at -70°C.

Adenylyl cyclase assay. Adenylyl cyclase activity was assayed according to the method of Salomon (1979). Membranes were thawed and then preincubated for 10 min at 37°C with adenosine deaminase (5 U/ml) to eliminate endogenous adenosine. The reaction mixture was prepared on ice with the final concentration of components as follows: 100 mM Tris-HCl (pH 7.4), 0.1 mM MgATP, 0.6 mM MgCl2, 1 mM EGTA, 10 µM GTP, 1 mM cAMP, 50 mM NaCl, 1 mM dithiothreitol, 10 mM creatine phosphate, creatine phosphokinase (7 U/ml), adenosine deaminase (5 U/ml), 32P-ATP (1 µCi/assay) and 3H-cAMP (0.02 µCi/assay). ISO, forskolin, AdoA1R agonists and antagonist were added according to the different protocols. The reaction mixture, containing everything but cardiac membranes, was preincubated at 37°C for 5 min. The reaction was initiated by adding membrane to the reaction mixture. After 30 min the reaction was terminated by adding stop solution that contained 2% sodium dodecyl sulfate, 25 mM ATP and 1.3 mM cAMP. The 32P-cAMP was isolated from 32P-ATP by the double-column procedure of Salomon (1979). Column eluates were collected and counted by liquid scintillation spectrometry. The recovery of cAMP was consistently 80% as determined by the recovery of 3H-cAMP. In all cAMP assays, membrane preparations from a single rat were assayed in triplicate. The data were expressed as picomoles of cAMP formed per minute per milligram of protein.

AdoA1R receptor binding assay. AdoA1R number in the cardiac membrane preparations was measured by radioligand binding assay with [3H]DPCPX, an AdoA1R antagonist. The reaction mixture (final volume, 0.2 ml) consisted of the following: 400 µg of membrane protein, 1 mM MgCl2, 0.01% CHAPS, 10 mM Tris (pH 7.4) and [3H]DPCPX (109 Ci/mmol, 0.05-4.0 nM). The reaction mixture was incubated at 25°C for 120 min. The reaction was terminated by adding 4 ml of ice-cold Tris buffer, and rapid filtering through Whatman GF/B filters with a Brandel Cell Harvester, followed by one additional wash with the same buffer. Filters were placed in scintillation liquid and counted by liquid scintillation spectrometry. The dissociation constant (Kd) and maximum binding capacity (Bmax) of [3H]DPCPX binding were determined by Scatchard analysis. The competition experiments were performed in the presence of [3H]DPCPX at a fixed concentration, approximately equal to its Kd, and varying concentrations of SPA with or without Gpp(NH)p. Nonspecific binding was determined by use of 330 µM SPA. In this binding assay, the specific binding was between 65 and 73%.

Statistical analysis. All data are expressed as mean ± S.E.M. Differences within and between groups (diet: AL and DR; age: 6, 12 and 24 months of age) were examined by ANOVA with multigroup comparisons, followed by Dunnett's test. Student's t test for unpaired data was used to analyze differences in radioligand Bmax and Kd. Statistical significance was defined as P < .05 and is indicated in the figures and text. EC50 was calculated with the linear regression program of StatView.

    Results
Top
Abstract
Introduction
Methods
Results
Discussion
References

Effect of age and DR on ISO-stimulated cAMP production. Isoproterenol caused a concentration-dependent increase in the activity of adenylyl cyclase in all age and diet groups (fig. 1). Table 1 indicates the maximal response to ISO at all ages. In AL rats, there was a significant decline in ISO-stimulated cAMP production between 6 and 12 months (36% reduction) and between 6 and 24 months (53% reduction). In contrast, in DR rats, the age-related decline in ISO-stimulated cAMP production was attenuated. There was only a 14% reduction between 6 and 12 months and a 24% reduction between 6 and 24 months. There were no significant differences in the EC50 for ISO between age and diet groups. Because a concentration of 100 µM caused a maximal stimulation at all ages and diets, this concentration was used to stimulate adenylyl cyclase in all subsequent experiments.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 1.   Concentration dependence of ISO-stimulated cAMP production in ventricular membranes of AL and DR rats. Each point represents the mean ± S.E.M. of five to six rats in each age and diet group. Data are expressed as picomoles per minute per milligram of protein obtained in a 30-min incubation. Twelve- and 24-month-old AL rats had significantly lower ISO-stimulated cAMP production than 6-month-old AL rats (ANOVA repeated measures, P < .001) and 12- and 24-month-old DR rats had significantly higher ISO-stimulated cAMP production than AL rats of the same age (ANOVA repeated measures, P < .01).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1
The effect of age and DR on ISO-stimulated adenylyl cyclase

Maximal response (Emax) (adenylyl cyclase activity, pmol/min/mg protein) and EC50 (µM) for ISO-stimulated adenylyl cyclase activity in cardiac ventricular membranes prepared from 6-, 12- and 24-month-old AL and DR rats. Data are presented as the mean ± S.E.M. of five to six rats in each age and diet group.

Effect of age and DR on AdoA1R-mediated inhibition of ISO-stimulated cAMP production. Previous work from this laboratory has demonstrated an age-related decline in the SPA-mediated inhibition of adenylyl cyclase (Gao et al., 1997). The effect of DR on the age-related decline in the effect of SPA (100 µM) is shown in figure 2. Basal and GTP-stimulated cyclase were not affected by either SPA or DR (data not shown). At 6 months, SPA inhibited ISO-stimulated adenylyl cyclase by 22% in AL rats and 20% in DR rats. Diet restriction attenuated the age-related decline in the SPA-mediated inhibition of adenylyl cyclase. At 12 months, SPA-mediated inhibition of adenylyl cyclase in DR rats was 14%, whereas the inhibition in AL rats was only 5%. Diet restriction caused a similar attenuation in the 24-month-old rats. Thus, DR attenuates the age-related decline in AdoA1R-mediated inhibition of adenylyl cyclase.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of age and DR on SPA-mediated inhibition of ISO-stimulated cAMP production. Assays were conducted in the presence of 100 µM ISO and in the presence and absence of 100 µM SPA. Data are expressed as the inhibitory effect of SPA as a percentage of the ISO response. The responses to ISO were as follows (pmol/min/mg protein): AL/6-month, 11.4 ± 0.8; DR/6-month, 12.0 ± 1.2; AL/12-month, 6.4 ± 0.3; DR/12-month, 8.4 ± 0.4; AL/24-month, 5.0 ± 0.2; DR/24-month, 8.2 ± 0.5. Values represent the mean ± S.E.M. of six to eight rats. *Inhibition of adenylyl cyclase activity by SPA in DR rats was significantly greater than in AL rats of the same age (t test, P < .05). **Inhibition of adenylyl cyclase by SPA was significantly less in 12- and 24-month-old AL rats than 6-month-old AL rats (ANOVA, P < .001). + Twelve- and 24-month-old DR rats were significantly less than 6-month-old DR rats (ANOVA, P < .05).   

Because the AdoA1R-mediated response is maintained in the 24-month-old rats, the receptor subtype mediating the inhibitory effect on adenylyl cyclase in the senescent animal could now be examined. 8-SPT, a specific AdoA1R antagonist, caused a concentration-dependent reduction in SPA-induced inhibition of ISO-stimulated adenylyl cyclase activity in 24-month-old DR rats (fig. 3). Consistent with our previous findings in 6- and 24-month-old AL rats, the EC50 for 8-SPT was approximately 0.7 µM in 24-month-old DR rats (Gao et al., 1997). This falls within the range of the Ki of 8-SPT for AdoA1Rs (Bruns et al., 1986; Shamin et al., 1989). Thus, the inhibition of adenylyl cyclase is mediated by the A1 receptor subtype at 24 months as well as at 6 months.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 3.   8-SPT blockade of SPA inhibition of ISO-stimulated cAMP production in 24-month-old DR rats. Assays were performed in the presence of 100 µM ISO, 100 µM SPA and 8-SPT (10-9-10-4). The control assay contained ISO and SPA only. The inhibitory effect of SPA on cyclase activity is expressed as the percentage inhibition of the ISO response. Adenylyl cyclase activity in this group (pmol/min/mg protein), 11.6 ± 0.8. Data are mean ± S.E.M. from four rats. *8-SPT significantly attenuated the inhibitory response to SPA (ANOVA, P < .05).

Effects of age and DR on AdoA1R-mediated inhibition of forskolin-stimulated adenylyl cyclase activity. Forskolin (10 µM) directly stimulates adenylyl cyclase activity, bypassing the need for beta adrenergic receptor stimulation (Seamon and Daly, 1986). Stimulation with forskolin, therefore, provides some indication of adenylyl cyclase activity. In our experiments, forskolin produced a much larger increase in adenylyl cyclase activity than ISO at all ages, which indicates high residual adenylyl cyclase activity even in senescent rat hearts. There was a significant age-related decline in forskolin-stimulated cAMP production between 6, 12 and 24 months in AL rats that was attenuated in DR rats (fig. 4). This suggests some decrease in adenylyl cyclase activity with age that is attenuated by DR.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of age and DR on forskolin-stimulated cAMP production. The concentration of forskolin was 10 µM. Data are expressed as picomoles per minute per milligram of protein obtained in a 30-min incubation. Values represent the mean ± S.E.M. of six to eight rats in each age and diet group. *DR rats were significantly greater than AL rats at 12 and 24 months (P < .05). **AL 12- and 24-month-old rats were significantly less than 6-month-old rats (P < .05). + DR 24-month-old rats were significantly less than 6-month-old DR rats (ANOVA, P < .05).

The effect of DR on the age-related decline in AdoA1R function was reexamined under various conditions with forskolin as a stimulus for adenylyl cyclase (fig. 5). SPA reduced cAMP production at 6 months by 20% in both AL and DR rats. At 12 months, inhibition of adenylyl cyclase in DR rats was 15%, whereas the inhibition in AL rats was only 6%. At 24 months, DR also partially reversed the decline in the inhibitory effect of SPA. Thus, DR maintains the ability of AdoA1R to inhibit adenylyl cyclase even when the enzyme is stimulated by nonreceptor mechanisms.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of age and DR on SPA-mediated inhibition of forskolin-stimulated adenylyl cyclase activity. Assays were performed in the presence of 10 µM forskolin in the presence and absence of 100 µM SPA. The inhibition of adenylyl cyclase activity by SPA was expressed as a percentage of the forskolin response. The responses to forskolin were as follows (pmol/min/mg protein): AL/6-month, 33.8 ± 1.9; DR/6-month, 34.1 ± 2.3; AL/12-month, 23.2 ± 0.9; DR/12-month, 28.7 ± 1.7; AL/24-month, 15.4 ± 1.5; DR/24-month, 24.5 ± 1.0. Values are mean ± S.E.M. of six to eight rats in each age and diet group. *Inhibition in DR rats was significantly greater than AL rats (P < .05). **AL 12- and 24-month-old rats were significantly less than 6-month-old rats (P < .05). + 24-month-old DR rats were significantly less than 6-month-old DR rats (ANOVA, P < .05).   

Effect of age and DR on AdoA1R density and G-protein coupling. To determine whether DR altered AdoA1R density, receptor number was determined in cardiac membranes from 6- and 24-month-old AL and DR rats by measuring saturation binding of the AdoA1R antagonist [3H]DPCPX (fig. 6). Scatchard analyses of the binding data revealed a linear curve for each age group, reflecting single affinity binding sites for the AdoA1R antagonist. Neither the Bmax nor the Kd changed with age in the AL and DR groups (table 2). Thus, the attenuation of the age-related decline in the effect of SPA is not caused by an increase in receptor number.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 6.   Specific [3H]DPCPX binding in ventricular membranes from 6- and 24-month-old AL and DR rats. Saturation binding curves were constructed from data with 0.05-4 nM 3H-DPCPX. Nonspecific binding was defined as the binding in the presence of 0.5 mM SPA. The inset graph represents the Scatchard plot of the binding data. Each graph presents the binding data from a single rat heart and represents the data obtained from all rats within each age group.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 2
The effect of age and DR on AdoA1R

Density and affinity of AdoA1R receptors in cardiac ventricular membrane preparations from 6- and 24-month-old AL and DR rats. Data are presented as the mean ± S.E.M. of six rats in each age and diet group.

To determine the effect of age on the affinity of the AdoA1R, we measured the ability of SPA to displace [3H]DPCPX. The displacement curve could be fitted to two sites, high and low affinity. We previously reported that the proportion of high-affinity binding sites decreases with age, from 55% at 6 months to 24% at 24 months (Cai et al., 1997). Analysis of the displacement curve obtained from similar experiments done with membranes from DR rats also showed two affinity binding sites at both ages (fig. 7). DR attenuated the decrease in high-affinity binding sites. Thus, at 24 months the percentage of high-affinity binding sites is 43% rather than 24% (table 3). The nonhydrolyzable GTP analog, Gpp(NH)p, shifted the agonist displacement curve for AdoA1R binding to the right in both 6- and 24-month-old DR rats to yield a single low-affinity binding site for the receptor. This indicates that all the sites can be uncoupled from G-proteins by adding excess GTP analog.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 7.   SPA-displacement curves of 3H-DPCPX binding in ventricular membranes from 6- (A) and 24-month-old (B) DR rats. Displacement experiments were performed in the presence of 0.3 nM 3H-DPCPX with increasing concentration of SPA (10-9-10-3 M). Specific binding data are presented as the percentage of control (without SPA). These values were (fmol/mg protein): DR/6-month/-Gpp(NH)p, 4.88 ± 0.3, + Gpp(NH)p 4.8 ± 0.3; DR/24-month/-Gpp(NH)p 5.89 ± 0.6, + Gpp(NH)p 5.0 ± 0.4. SPA displacement of 3H-DPCPX binding was determined in the presence (bullet ) and absence (open circle ) of 100 µM Gpp(NH)p. Data are mean ± S.E.M of seven animals from each group.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 3
Two-site fit of competition binding curves for AdoA1R

High and low agonist affinity binding constants for SPA in the absence or presence of 100 µM Gpp(NH)p in ventricular membrane preparations from 6- and 24-month-old DR rats. Data are mean ± S.E.M. from seven rats.

    Discussion
Top
Abstract
Introduction
Methods
Results
Discussion
References

The present studies confirm our previous observations that AdoA1R-mediated function decreases with age in the rat heart (Gao et al., 1997) and that decreased AdoA1R function is not caused by changes in AdoA1R number. New to this article is the observation that DR attenuates the age-related decline in AdoA1R-mediated function, as well as the decrease in AdoA1R coupling to G-protein. These studies provide additional evidence that the protective, antiadrenergic function of the AdoA1R is diminished in the aged heart.

The age-related decline in AdoA1R function may be caused by changes in the receptor number with age. However, our studies indicate that there is no change in receptor number with age in either AL or DR rats. There are reports of increased AdoA1R density in the senescent heart (Montamat et al., 1996; Romano and Dobson, 1996). We cannot account for these differences except for fact that the reported Kd for [3H]DPCPX in the Romano and Dobson (1996) study was 2 nM, which is much higher than the one reported in these studies. Furthermore, in those studies the Kd increased with age, whereas in our study there was no change with age. The study of Montamat et al. (1996) was done in atria rather than ventricle. Perhaps different methods of membrane preparation could account for the differences.

An age-related change in the number of Galpha i guanine nucleotide regulatory proteins could also account for the decline in AdoA1R function in old male rat hearts. The alpha subunit of Gi is present in three isoforms (Gialpha 1, Gialpha 2, Gialpha 3) which have been identified by molecular cloning (Birnbaumer et al., 1985; Itoh et al., 1986; Jones and Reed, 1987). All these isoforms have been shown to inhibit adenylyl cyclase activity (Kobayashi et al., 1990). Studies from our laboratory have demonstrated that AdoA1R is coupled to Galpha i3 and Galpha o (Cai et al., 1997). Consistent with previous studies (Shu and Scarpace 1994; Johnson et al., 1995), we have found no change in Galpha i levels or the distribution among the isoforms in the hearts of F344 rats between 6 and 24 months of age. These data indicate that the loss of AdoA1R function in aging hearts is probably not caused by decreased G-protein levels.

Our studies have shown that decreased AdoA1R function in the senescent rat heart is not caused by changes in AdoA1R number or to changes in Gi levels, but rather by alterations in receptor/G-protein coupling. The state of receptor/G-protein coupling determines the affinity of the receptor for agonists such as SPA. Thus, the percentage of high-affinity receptor sites is a reflection of the number of receptors precoupled to G-proteins. The age-related decrease in high-affinity receptors suggests a decrease in the number of receptors precoupled to G-proteins. Consistent with this observation Cai et al. (1997) have shown age-related decrease in the ability of SPA to induce coupling of Galpha i3 and Galpha o to the AdoA1R. Thus, age attenuates precoupling and receptor-stimulated coupling of AdoA1R. Thus, DR attenuates age-related changes that potentially could lead to the decrease in AdoA1R coupling.

Other studies also suggest that DR can attenuate age-related changes in receptor function. Dietary restriction prevents the age-related increase in rat liver beta receptors (Katz 1988; Dax et al., 1989). Dietary restriction alters or attenuates the age-related decline alpha-1 adrenoceptor responsiveness in various tissues (Gurdal et al., 1995; Chen et al., 1997). Chen et al. (1997) showed that the effect of DR is the result of altered G-protein binding to rat parotid cell membrane. Although it is clear from our data and others that DR affects receptor/G-protein coupling, the mechanism for the decrease is not clear. DR may exert its effect by altering membrane fluidity (Benedetti et al., 1988) or by preventing peroxidative damage to membranes (Viani et al., 1991).

Our results also indicate that DR reverses the decrease in beta adrenergic receptor function. It is well established that there is an age-related decrease in beta adrenergic receptor-mediated stimulation of adenylyl cyclase activity (O'Connor et al., 1981, 1983; Narayanan and Derby, 1982) and of cardiac contraction (Abrass et al., 1982). However, there are only a few reports on the effect of DR on beta adrenergic responses (Herlihy and Kim, 1994). In young adult rats, DR increased the inotropic response of electrically driven left atria to ISO; however, no senescent animals were examined in this study (Herlihy, 1984). Scarpace and Yu (1987) showed that DR enhanced the ISO-stimulated adenylyl cyclase activity from lungs of both young and old rats. Similar to what has been suggested regarding the AdoA1R by this manuscript, it has been proposed that the age-related decrease in beta adrenergic receptor function is caused by a failure to form high-affinity agonist-receptor complexes (Narayanan and Derby, 1982; Scarpace and Abrass, 1986), a decrease in the amount of adenylyl cyclase (Scarpace, 1990; Shu and Scarpace, 1994) and/or decreased receptor coupling to G-proteins (Insel, 1993; Gurdal et al., 1995).

Dobson et al. (1990) and Romano and Dobson (1996) have proposed that an increase in the antiadrenergic actions of adenosine is responsible for the age-related decrease in beta adrenergic receptor-mediated responses in the heart. In our experiments, endogenous adenosine is removed by adding adenosine deaminase; therefore, the decrease in beta adrenergic-mediated stimulation of adenylyl cyclase in senescent rat hearts is most likely not caused by excessive adenosine. In fact our data suggest some type of equilibrium that may mitigate age-related decreases in beta adrenergic-stimulated adenylyl cyclase. Thus, the ultimate increase in adenylyl cyclase within heart tissue may be the same because there is also less inhibition by AdoA1R. On the other hand, there are redundant mechanisms for the inhibition of cyclase such as stimulation of muscarinic receptors that do not decrease with age (Gao et al., 1997). In this case there would be less increase in cyclase in the senescent rat.

In summary, the present study provides evidence that ISO- and forskolin-stimulated cAMP production and AdoA1R-mediated antiadrenergic responses decline with age in the male rat heart and that these changes occur as early as 12 months of age. The age-related decline in AdoA1R-mediated antiadrenergic responses are not caused by changes in receptor density, but may be caused by decreases in receptor G-protein coupling. Dietary restriction attenuated the age-related decline in beta adrenoceptor-mediated and forskolin-stimulated activation of adenylyl cyclase and AdoA1R-mediated antiadrenergic responses. Our results indicate that DR maintains AdoA1R function during aging by maintaining receptor/G-protein coupling.

    Acknowledgments

N6-p-Sulfophenyladenosine was provided by Research Biochemicals International (Natick, MA) as part of the Chemical Synthesis Program of the National Institute of Mental Health, Contract N01 MH30003.

    Footnotes

Accepted for publication December 10, 1997.

Received for publication June 18, 1997.

1 This study was supported in part by grants from the National Institutes of Health (KO7 AG 00532, AG 11060) and the Allegheny Health Education Research Foundation.

Send reprint requests to: Dr. Joel Horwitz, Department of Pharmacology, Allegheny University of the Health Sciences, MCP black-diamond  Hahnemann School of Medicine, 3200 Henry Ave., Philadelphia, PA 19129.

    Abbreviations

DR , diet restriction; AL, ad libitum; AdoA1R, adenosine A1 receptor; ISO, isoproterenol; SPA, N6-p-sulfophenyladenosine; 8-SPT, 8-p-sulfophenyltheophylline; 3H-DPCPX, cyclopentyl-1,3-dipropylxanthine, 8-[dipropyl-2,3-3H], Gpp(NH)p-5'-guanylylimidodiphosphate; EGTA, ethyleneglycol-bis(beta -aminoethyl ether)-N,N,N',N'-tetraacetic acid; EDTA, ethylenediaminetetraacetic acid; HEPES, N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid; ANOVA, analysis of variance; CHAPS, 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate.

    References
Top
Abstract
Introduction
Methods
Results
Discussion
References


0022-3565/98/2851-0186$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Abete, G. Testa, N. Ferrara, D. De Santis, P. Capaccio, L. Viati, C. Calabrese, F. Cacciatore, G. Longobardi, M. Condorelli, et al.
Cardioprotective effect of ischemic preconditioning is preserved in food-restricted senescent rats
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H1978 - H1987.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Gao, T. A. Christopher, B. L. Lopez, E. Friedman, G. Cai, and X. L. Ma
Mechanism of decreased adenosine protection in reperfusion injury of aging rats
Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H329 - H338.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Abete, G. Testa, N. Ferrara, D. De Santis, P. Capaccio, L. Viati, C. Calabrese, F. Cacciatore, G. Longobardi, M. Condorelli, et al.
Cardioprotective effect of ischemic preconditioning is preserved in food-restricted senescent rats
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H1978 - H1987.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gao, E.
Right arrow Articles by Horwitz, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gao, E.
Right arrow Articles by Horwitz, J.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition